AAD

home / conference / aad

Patient Care Online provides primary care physicians with essential insights from the 2025 American Academy of Dermatology (AAD) Annual Meeting. Access expert guidance, clinical updates, and actionable content on the latest advancements in dermatologic care—all tailored to enhance your practice and patient outcomes.

Conference Highlights

Expert Interviews

Featured

Emergence of Trichophyton Indotineae: A Call for Culture-Driven Antifungal Therapy

Elizabeth Swanson, MD, FAAD

Sydney Jennings

Daniel Butler, MD, a Leader in Geriatric Dermatology, Says Focus on the Overlap in the Etiology of Itch in Older Adults

Daniel Butler, MD

Rethinking Shingles in Children: Expert Insights for Primary Care

Elizabeth Swanson, MD, FAAD

Sydney Jennings

Measles Resurgence and Vaccine Efficacy: A Conversation with Elizabeth Swanson, MD

Elizabeth Swanson, MD, FAAD

Sydney Jennings

Upadacitinib Demonstrates Superior Regional, Overall Efficacy vs Dupilumab in Atopic Dermatitis: Level Up Phase 3b/4 Trial Findings

Hand, Foot, and Mouth Disease Update: A Conversation with Elizabeth Swanson, MD

Elizabeth Swanson, MD, FAAD

Sydney Jennings

JiaDe Yu, MD: When to Refer Pediatric Patients with Suspected Contact Dermatitis

Sydney Jennings

Advances in Understanding of Itch: A Conversation with Brian S Kim, MD, MTR, at the 2025 AAD Meeting

Brian S. Kim, MD

Atopic Dermatitis of Childhood Onset Significantly Impacts "Life Trajectory" According to Scars of Life Survey

Advances in Dermatology Therapeutics: Key Insights from AAD 2025

Sydney Jennings

JiaDe Yu, MD: Key Signs of Allergic Contact Dermatitis in Children

Sydney Jennings

Elizabeth Swanson, MD: When HSV Causes Big Dermatologic Problems

Elizabeth Swanson, MD, FAAD

Sydney Jennings

For Atopic Dermatitis, "The Treatment Drought is Over," Says Expert Dermatologist Emma Guttman, MD, PhD

Delgocitinib Data Reveal "Super Responders" in CHE During AAD 2025 Late Breaker

Recognizing Allergic Contact Dermatitis in Children: Expert Pearls at AAD 2025

Sydney Jennings

Brian S. Kim, MD: Why Primary Care Clinicians Should Prescribe New Treatments for Atopic Dermatitis

Brian S. Kim, MD

Zabalafin Hydrogel Shows Efficacy in Atopic Dermatitis, Including Cases with Bacterial Infection

Patient Care Editorial Staff

The Link Between Itch and Aging, with Daniel Butler, MD

Daniel Butler, MD

The Complexities of Treating Rosacea, with Benjamin Ungar, MD

Benjamin Ungar, MD

Sydney Jennings

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Linda Stein Gold, MD

Sydney Jennings

Daniel Butler, MD: Pearls for Primary Care When Treating and Referring Older Adults for Chronic Itch

Daniel Butler, MD

Rocatinlimab, an OX40 Inhibitor, Achieves Positive Results in Atopic Dermatitis Treatment: ROCKET-Horizon Topline Findings

Atopic Dermatitis Breakthrough: Linda Stein Gold, MD, on Tapinarof's Treatment-Free Benefits

Sydney Jennings

Benjmain Ungar, MD: Addressing the Immunological Causes of Seborrheic Dermatitis

Benjamin Ungar, MD

Sydney Jennings

Dupilumab Demonstrates Superior Long-Term Persistence Over Upadacitinib and Tralokinumab in Atopic Dermatitis

Atopic Dermatitis: Investigational Anti-OX40L Antibody Shows Sustained Itch Relief, Even After Discontinuation

Sydney Jennings

Atopic Dermatitis: It’s Not the Food, I Promise You

Peter A Lio, MD

Ruxolitinib Cream 1.5% Demonstrates Efficacy in Prurigo Nodularis: Phase 3 Findings

Patient Care Editorial Staff

Rocatinlimab Shows Significant Efficacy in Moderate to Severe Atopic Dermatitis: Phase 3 IGNITE Trial Results

Icotrokinra Shows Promise for Moderate-to-Severe Plaque Psoriasis in Phase 3 Trials

Patient Care Editorial Staff

Editorial Board

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.